Skip to content

Impact of Frailty in Patients with Severe Functional Tricuspid Regurgitation

Impact of Frailty in Patients with Severe Functional Tricuspid Regurgitation - Impact of frailty in FTR

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000030438
Enrollment
150
Registered
2017-12-17
Start date
2016-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe Functional Tricuspid Regurgitation

Interventions

None listed

Sponsors

Sakakibara Heart Institute
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria includes patients with severe functional TR undergoing transthoracic echocardiography at the Sakakibara Heart Institute from November 2016.

Exclusion criteria

Exclusion criteria: Exclusion criteria includes age <20 years, TR with leaflet abnormality (primary TR), <moderate TR, untreated clinically significant coronary artery / valvular / aortic disease requiring interventions, any therapeutic invasive cardiac procedure performed within 6 months of the index procedure, active infections, and currently participating in an investigational drug or another device study.

Design outcomes

Primary

MeasureTime frame
Mortality(cardiac, non-cardiac), admission due to heart failure

Countries

Japan

Contacts

Public ContactMike Saji

Sakakibara Heart Institute Cardiology

mikesaji8@gmail.com042-314-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026